New Square Capital LLC Infinity Pharmaceuticals, Inc. Transaction History

New Square Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$1.05 - $2.77 $73,025 - $192,647	-69,548 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$1.18 - $1.91 $40,766 - $65,986	34,548 Added 98.71%	69,548 $131,000
Q3 2018 Oct 19, 2018	BUY	$1.72 - $2.71 $60,200 - $94,850	35,000 New	35,000 $95,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.